Kush Sharma, MD
Vascular Surgery · Rancho Mirage, CANPI 1427578004
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (40.0%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 26 manufacturers reported payments, led by Shockwave Medical, Inc at 42.0% of the total. 2025 is the largest year on record at $36,943, more than ten times the $1,171 reported in 2019. Among vascular surgery clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 179 payments — averaging $272.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Shockwave Medical, Inc$20K
- Medtronic$18K
- W. L. Gore & Associates, Inc.$3K
- Silk Road Medical, Inc.$3K
- Cook Medical LLC$2K
- Cardiovascular Systems Inc.$781
- plus $2K from 20 others
What the payments were for
- Consulting fees$19,55040%
- Speaking & faculty fees$15,98033%
- Grants$1,3943%
- Travel & lodging$1,4073%
- Food & beverage$9,70420%
- Education$7932%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Shockwave Medical, Inc | 23 | $20,486 |
| Medtronic(2 entities) | 32 | $17,552 |
| W. L. Gore & Associates, Inc. | 49 | $3,202 |
| Silk Road Medical, Inc. | 13 | $2,592 |
| Cook Medical LLC | 11 | $2,097 |
| Cardiovascular Systems Inc. | 15 | $781 |
| Boston Scientific | 3 | $335 |
| Endologix LLC | 3 | $238 |
| Bolton Medical Inc | 5 | $207 |
| Johnson & Johnson(2 entities) | 3 | $177 |
| Angiodynamics, Inc. | 2 | $154 |
| Cagent Vascular Inc | 1 | $150 |
| Inari Medical, Inc. | 1 | $133 |
| Penumbra, Inc. | 1 | $131 |
| Terumo Medical Corporation | 1 | $112 |
| Lemaitre Vascular, Inc. | 2 | $103 |
| Getinge USA Sales, LLC | 2 | $90 |
| Alphatec Spine, Inc | 2 | $79 |
| Cardinal Health 200 LLC | 1 | $55 |
| Abbott | 2 | $39 |
| Pfizer | 2 | $35 |
| Janssen Scientific Affairs, LLC | 1 | $21 |
| Integra Lifesciences Corporation | 1 | $19 |
| Bard Peripheral Vascular, Inc. | 1 | $16 |
| Masimo Corporation | 1 | $13 |
| Baxter Healthcare | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$20,348
- ENDURANT IIS$15,071
- ENROUTE Transcarotid Neuroprotection System$3,961
- ENROUTE Transcarotid Stent$2,379
- Valiant Captivia$1,700
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$1,683
- Peripheral Orbital Atherectomy System$477
- GORE TAG Thoracic Endoprosthesis$471
- GORE EXCLUDER AAA Endoprosthesis$464
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$412
- Vascular Graft$391
- GORE TAG Thoracic Branch Endoprosthesis$323
- TAG Thoracic Endoprosthesis$195
- Serrantor$150
- XARELTO$140
- PERFORMER$139
- Relay Grafts$134
- FLOWTRIEVER CATHETER, S$133
- CT THROMBECTOMY SYSTEM KIT$133
- Real Immersive System$131
How this compares
$48,828 in reported general payments places this provider in the 90th percentile of 519 vascular surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 14 | $8,100 |
| ClopidogrelClopidogrel Bisulfate | 148 | $1,478 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 54 | $227 |
| Atorvastatin Calcium | 13 | $91 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $35 | $8,10014 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 519 vascular surgery providers in California.
Other vascular surgery in Rancho Mirage
- Trevor DerderianRancho Mirage$359K
- Son DuongFountain Valley$503K
- Venita ChandraPalo Alto$488K
- Sukgu HanLos Angeles$477K
- Leigh Ann ObanionFresno$469K
- Karthikeshwar KasirajanPalo Alto$349K
- Johnathon RolloLos Angeles$337K
- Melissa LojaFairfield$272K
- Jason LeePalo Alto$228K
- John LaneSan Diego$212K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.